nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Hypokalaemia—Crizotinib—lung cancer	0.0256	0.0291	CcSEcCtD
Alvimopan—Hypokalaemia—Gefitinib—lung cancer	0.0232	0.0264	CcSEcCtD
Alvimopan—Urinary tract disorder—Crizotinib—lung cancer	0.0192	0.0218	CcSEcCtD
Alvimopan—Urethral disorder—Crizotinib—lung cancer	0.0191	0.0217	CcSEcCtD
Alvimopan—Urinary tract disorder—Pemetrexed—lung cancer	0.0175	0.02	CcSEcCtD
Alvimopan—Urinary tract disorder—Gefitinib—lung cancer	0.0174	0.0198	CcSEcCtD
Alvimopan—Urethral disorder—Pemetrexed—lung cancer	0.0174	0.0198	CcSEcCtD
Alvimopan—Urethral disorder—Gefitinib—lung cancer	0.0173	0.0197	CcSEcCtD
Alvimopan—Malnutrition—Crizotinib—lung cancer	0.0169	0.0193	CcSEcCtD
Alvimopan—Anaemia—Crizotinib—lung cancer	0.0156	0.0178	CcSEcCtD
Alvimopan—Malnutrition—Pemetrexed—lung cancer	0.0155	0.0176	CcSEcCtD
Alvimopan—Malnutrition—Gefitinib—lung cancer	0.0154	0.0175	CcSEcCtD
Alvimopan—Anaemia—Pemetrexed—lung cancer	0.0143	0.0163	CcSEcCtD
Alvimopan—Anaemia—Gefitinib—lung cancer	0.0142	0.0162	CcSEcCtD
Alvimopan—Hypokalaemia—Erlotinib—lung cancer	0.0139	0.0158	CcSEcCtD
Alvimopan—Dyspepsia—Crizotinib—lung cancer	0.0122	0.0138	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Crizotinib—lung cancer	0.0119	0.0136	CcSEcCtD
Alvimopan—Constipation—Crizotinib—lung cancer	0.0118	0.0134	CcSEcCtD
Alvimopan—Anaemia—Teniposide—lung cancer	0.0116	0.0132	CcSEcCtD
Alvimopan—Dyspepsia—Pemetrexed—lung cancer	0.0111	0.0126	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pemetrexed—lung cancer	0.0109	0.0124	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Gefitinib—lung cancer	0.0108	0.0123	CcSEcCtD
Alvimopan—Constipation—Pemetrexed—lung cancer	0.0108	0.0123	CcSEcCtD
Alvimopan—Constipation—Gefitinib—lung cancer	0.0107	0.0122	CcSEcCtD
Alvimopan—Urinary tract disorder—Erlotinib—lung cancer	0.0104	0.0119	CcSEcCtD
Alvimopan—Connective tissue disorder—Erlotinib—lung cancer	0.0104	0.0118	CcSEcCtD
Alvimopan—Urethral disorder—Erlotinib—lung cancer	0.0103	0.0118	CcSEcCtD
Alvimopan—Hypokalaemia—Irinotecan—lung cancer	0.0099	0.0113	CcSEcCtD
Alvimopan—Hypokalaemia—Gemcitabine—lung cancer	0.00964	0.011	CcSEcCtD
Alvimopan—Malnutrition—Topotecan—lung cancer	0.00928	0.0106	CcSEcCtD
Alvimopan—Malnutrition—Erlotinib—lung cancer	0.00918	0.0105	CcSEcCtD
Alvimopan—Flatulence—Erlotinib—lung cancer	0.00905	0.0103	CcSEcCtD
Alvimopan—Hypokalaemia—Cisplatin—lung cancer	0.00899	0.0102	CcSEcCtD
Alvimopan—Back pain—Topotecan—lung cancer	0.00898	0.0102	CcSEcCtD
Alvimopan—Connective tissue disorder—Vinorelbine—lung cancer	0.00896	0.0102	CcSEcCtD
Alvimopan—Back pain—Erlotinib—lung cancer	0.00888	0.0101	CcSEcCtD
Alvimopan—Anaemia—Vinblastine—lung cancer	0.00883	0.0101	CcSEcCtD
Alvimopan—Anaemia—Topotecan—lung cancer	0.00858	0.00976	CcSEcCtD
Alvimopan—Hypokalaemia—Paclitaxel—lung cancer	0.00807	0.00919	CcSEcCtD
Alvimopan—Malnutrition—Vinorelbine—lung cancer	0.00794	0.00904	CcSEcCtD
Alvimopan—Back pain—Vinorelbine—lung cancer	0.00768	0.00874	CcSEcCtD
Alvimopan—Connective tissue disorder—Irinotecan—lung cancer	0.00739	0.00841	CcSEcCtD
Alvimopan—Ketoprofen—CXCL8—lung cancer	0.00736	0.484	CrCbGaD
Alvimopan—Anaemia—Vinorelbine—lung cancer	0.00734	0.00835	CcSEcCtD
Alvimopan—Urinary tract disorder—Gemcitabine—lung cancer	0.00724	0.00824	CcSEcCtD
Alvimopan—Connective tissue disorder—Gemcitabine—lung cancer	0.0072	0.00819	CcSEcCtD
Alvimopan—Urethral disorder—Gemcitabine—lung cancer	0.00718	0.00817	CcSEcCtD
Alvimopan—Urinary tract disorder—Cisplatin—lung cancer	0.00675	0.00768	CcSEcCtD
Alvimopan—Connective tissue disorder—Cisplatin—lung cancer	0.00671	0.00764	CcSEcCtD
Alvimopan—Urethral disorder—Cisplatin—lung cancer	0.0067	0.00762	CcSEcCtD
Alvimopan—Constipation—Vinblastine—lung cancer	0.00667	0.00759	CcSEcCtD
Alvimopan—Dyspepsia—Topotecan—lung cancer	0.00667	0.00759	CcSEcCtD
Alvimopan—Dyspepsia—Erlotinib—lung cancer	0.0066	0.00751	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Topotecan—lung cancer	0.00654	0.00744	CcSEcCtD
Alvimopan—Constipation—Topotecan—lung cancer	0.00648	0.00737	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Erlotinib—lung cancer	0.00647	0.00736	CcSEcCtD
Alvimopan—Flatulence—Irinotecan—lung cancer	0.00645	0.00734	CcSEcCtD
Alvimopan—Constipation—Erlotinib—lung cancer	0.00641	0.00729	CcSEcCtD
Alvimopan—Back pain—Irinotecan—lung cancer	0.00634	0.00721	CcSEcCtD
Alvimopan—Urinary tract disorder—Etoposide—lung cancer	0.00618	0.00703	CcSEcCtD
Alvimopan—Back pain—Gemcitabine—lung cancer	0.00617	0.00702	CcSEcCtD
Alvimopan—Urethral disorder—Etoposide—lung cancer	0.00613	0.00698	CcSEcCtD
Alvimopan—Urinary tract disorder—Paclitaxel—lung cancer	0.00606	0.0069	CcSEcCtD
Alvimopan—Anaemia—Irinotecan—lung cancer	0.00605	0.00689	CcSEcCtD
Alvimopan—Connective tissue disorder—Paclitaxel—lung cancer	0.00603	0.00686	CcSEcCtD
Alvimopan—Urethral disorder—Paclitaxel—lung cancer	0.00602	0.00684	CcSEcCtD
Alvimopan—Malnutrition—Cisplatin—lung cancer	0.00595	0.00677	CcSEcCtD
Alvimopan—Anaemia—Gemcitabine—lung cancer	0.0059	0.00671	CcSEcCtD
Alvimopan—Flatulence—Cisplatin—lung cancer	0.00586	0.00667	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Vinorelbine—lung cancer	0.0056	0.00637	CcSEcCtD
Alvimopan—Constipation—Vinorelbine—lung cancer	0.00554	0.00631	CcSEcCtD
Alvimopan—Anaemia—Cisplatin—lung cancer	0.0055	0.00625	CcSEcCtD
Alvimopan—Malnutrition—Paclitaxel—lung cancer	0.00534	0.00608	CcSEcCtD
Alvimopan—Back pain—Etoposide—lung cancer	0.00527	0.006	CcSEcCtD
Alvimopan—Flatulence—Paclitaxel—lung cancer	0.00526	0.00599	CcSEcCtD
Alvimopan—Back pain—Paclitaxel—lung cancer	0.00517	0.00588	CcSEcCtD
Alvimopan—Urinary tract disorder—Docetaxel—lung cancer	0.00514	0.00584	CcSEcCtD
Alvimopan—Connective tissue disorder—Docetaxel—lung cancer	0.00511	0.00582	CcSEcCtD
Alvimopan—Urethral disorder—Docetaxel—lung cancer	0.0051	0.0058	CcSEcCtD
Alvimopan—Anaemia—Etoposide—lung cancer	0.00504	0.00573	CcSEcCtD
Alvimopan—Anaemia—Paclitaxel—lung cancer	0.00494	0.00562	CcSEcCtD
Alvimopan—Dyspepsia—Irinotecan—lung cancer	0.00471	0.00535	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Irinotecan—lung cancer	0.00461	0.00525	CcSEcCtD
Alvimopan—Constipation—Irinotecan—lung cancer	0.00457	0.0052	CcSEcCtD
Alvimopan—Malnutrition—Docetaxel—lung cancer	0.00453	0.00515	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Gemcitabine—lung cancer	0.0045	0.00512	CcSEcCtD
Alvimopan—Constipation—Gemcitabine—lung cancer	0.00445	0.00507	CcSEcCtD
Alvimopan—Back pain—Docetaxel—lung cancer	0.00438	0.00498	CcSEcCtD
Alvimopan—Hypokalaemia—Doxorubicin—lung cancer	0.00427	0.00486	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Cisplatin—lung cancer	0.00419	0.00477	CcSEcCtD
Alvimopan—Anaemia—Docetaxel—lung cancer	0.00418	0.00476	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Etoposide—lung cancer	0.00384	0.00437	CcSEcCtD
Alvimopan—Dyspepsia—Paclitaxel—lung cancer	0.00384	0.00437	CcSEcCtD
Alvimopan—Constipation—Etoposide—lung cancer	0.0038	0.00433	CcSEcCtD
Alvimopan—Indinavir—ABCB1—lung cancer	0.0038	0.25	CrCbGaD
Alvimopan—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00376	0.00428	CcSEcCtD
Alvimopan—Constipation—Paclitaxel—lung cancer	0.00373	0.00424	CcSEcCtD
Alvimopan—Urinary tract disorder—Methotrexate—lung cancer	0.0037	0.00421	CcSEcCtD
Alvimopan—Urethral disorder—Methotrexate—lung cancer	0.00367	0.00418	CcSEcCtD
Alvimopan—Malnutrition—Methotrexate—lung cancer	0.00326	0.00371	CcSEcCtD
Alvimopan—Dyspepsia—Docetaxel—lung cancer	0.00325	0.0037	CcSEcCtD
Alvimopan—Urinary tract disorder—Doxorubicin—lung cancer	0.00321	0.00365	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Docetaxel—lung cancer	0.00319	0.00363	CcSEcCtD
Alvimopan—Connective tissue disorder—Doxorubicin—lung cancer	0.00319	0.00363	CcSEcCtD
Alvimopan—Urethral disorder—Doxorubicin—lung cancer	0.00318	0.00362	CcSEcCtD
Alvimopan—Constipation—Docetaxel—lung cancer	0.00316	0.0036	CcSEcCtD
Alvimopan—Back pain—Methotrexate—lung cancer	0.00316	0.00359	CcSEcCtD
Alvimopan—Anaemia—Methotrexate—lung cancer	0.00302	0.00343	CcSEcCtD
Alvimopan—Malnutrition—Doxorubicin—lung cancer	0.00283	0.00322	CcSEcCtD
Alvimopan—Flatulence—Doxorubicin—lung cancer	0.00278	0.00317	CcSEcCtD
Alvimopan—Back pain—Doxorubicin—lung cancer	0.00273	0.00311	CcSEcCtD
Alvimopan—Anaemia—Doxorubicin—lung cancer	0.00261	0.00297	CcSEcCtD
Alvimopan—Dyspepsia—Methotrexate—lung cancer	0.00234	0.00267	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Methotrexate—lung cancer	0.0023	0.00262	CcSEcCtD
Alvimopan—Ketoprofen—PTGS2—lung cancer	0.00215	0.141	CrCbGaD
Alvimopan—Dyspepsia—Doxorubicin—lung cancer	0.00203	0.00231	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00199	0.00227	CcSEcCtD
Alvimopan—Constipation—Doxorubicin—lung cancer	0.00197	0.00224	CcSEcCtD
Alvimopan—Ketoprofen—ALB—lung cancer	0.00191	0.126	CrCbGaD
Alvimopan—OPRD1—Signaling Pathways—ANXA1—lung cancer	0.00012	0.00113	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SMARCA4—lung cancer	0.000117	0.00111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PPP2R1B—lung cancer	0.000117	0.00111	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FLT1—lung cancer	0.000116	0.00109	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CG—lung cancer	0.000115	0.00108	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APP—lung cancer	0.000114	0.00107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOTCH3—lung cancer	0.000114	0.00107	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HSPB1—lung cancer	0.000113	0.00107	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNG11—lung cancer	0.000113	0.00107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF9—lung cancer	0.000113	0.00106	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTHLH—lung cancer	0.000112	0.00105	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL8—lung cancer	0.000111	0.00105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AVP—lung cancer	0.000111	0.00105	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—POMC—lung cancer	0.000109	0.00103	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFC—lung cancer	0.000108	0.00101	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JUNB—lung cancer	0.000108	0.00101	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ANXA1—lung cancer	0.000105	0.000991	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CG—lung cancer	0.000104	0.000985	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FLT1—lung cancer	0.000102	0.00096	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADCY1—lung cancer	0.000102	0.000958	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CD—lung cancer	0.000101	0.000953	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CG—lung cancer	0.000101	0.000951	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APP—lung cancer	9.96e-05	0.00094	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOTCH3—lung cancer	9.96e-05	0.00094	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—POMC—lung cancer	9.93e-05	0.000937	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	9.9e-05	0.000934	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SMARCA4—lung cancer	9.9e-05	0.000934	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF9—lung cancer	9.87e-05	0.000932	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STK11—lung cancer	9.76e-05	0.000921	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6R—lung cancer	9.69e-05	0.000914	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—lung cancer	9.59e-05	0.000905	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HSPB1—lung cancer	9.55e-05	0.000901	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTHLH—lung cancer	9.44e-05	0.000891	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUNB—lung cancer	9.43e-05	0.00089	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FOXO3—lung cancer	9.42e-05	0.000889	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—MAP2K1—lung cancer	9.23e-05	0.000872	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CD—lung cancer	9.17e-05	0.000866	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CG—lung cancer	9.15e-05	0.000864	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ANXA1—lung cancer	8.88e-05	0.000838	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CD—lung cancer	8.86e-05	0.000836	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AVP—lung cancer	8.83e-05	0.000833	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CB—lung cancer	8.8e-05	0.000831	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—lung cancer	8.71e-05	0.000822	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FLT1—lung cancer	8.6e-05	0.000811	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STK11—lung cancer	8.56e-05	0.000808	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	8.52e-05	0.000804	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF1R—lung cancer	8.5e-05	0.000802	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6R—lung cancer	8.5e-05	0.000802	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—lung cancer	8.46e-05	0.000799	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APP—lung cancer	8.41e-05	0.000794	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOTCH3—lung cancer	8.41e-05	0.000794	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HES1—lung cancer	8.35e-05	0.000788	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF9—lung cancer	8.34e-05	0.000788	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FOXO3—lung cancer	8.26e-05	0.00078	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RAF1—lung cancer	8.19e-05	0.000773	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—lung cancer	8.11e-05	0.000765	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	8.1e-05	0.000764	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—lung cancer	8.09e-05	0.000763	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	8.04e-05	0.000759	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	8e-05	0.000755	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUNB—lung cancer	7.97e-05	0.000752	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AVP—lung cancer	7.74e-05	0.000731	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	7.73e-05	0.00073	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	7.72e-05	0.000729	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—lung cancer	7.68e-05	0.000725	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ERBB3—lung cancer	7.63e-05	0.00072	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	7.49e-05	0.000707	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF1R—lung cancer	7.45e-05	0.000703	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	7.42e-05	0.0007	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—lung cancer	7.36e-05	0.000695	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—lung cancer	7.34e-05	0.000693	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HES1—lung cancer	7.32e-05	0.000691	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TERT—lung cancer	7.32e-05	0.000691	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STK11—lung cancer	7.24e-05	0.000683	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RAF1—lung cancer	7.18e-05	0.000678	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6R—lung cancer	7.18e-05	0.000678	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGFR1—lung cancer	7.1e-05	0.00067	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—lung cancer	7.09e-05	0.000669	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	7.01e-05	0.000662	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HIF1A—lung cancer	7e-05	0.00066	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FOXO3—lung cancer	6.98e-05	0.000659	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	6.84e-05	0.000646	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	6.8e-05	0.000642	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOA1—lung cancer	6.75e-05	0.000637	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—lung cancer	6.74e-05	0.000636	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ERBB3—lung cancer	6.69e-05	0.000632	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KDR—lung cancer	6.69e-05	0.000632	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AVP—lung cancer	6.54e-05	0.000618	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	6.52e-05	0.000616	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—lung cancer	6.44e-05	0.000608	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TERT—lung cancer	6.42e-05	0.000605	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF1R—lung cancer	6.3e-05	0.000594	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	6.27e-05	0.000592	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGFR1—lung cancer	6.23e-05	0.000588	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HES1—lung cancer	6.19e-05	0.000584	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APC—lung cancer	6.16e-05	0.000582	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CG—lung cancer	6.16e-05	0.000582	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KIT—lung cancer	6.16e-05	0.000582	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—NRAS—lung cancer	6.16e-05	0.000582	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HIF1A—lung cancer	6.14e-05	0.000579	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGF—lung cancer	6.09e-05	0.000575	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RAF1—lung cancer	6.07e-05	0.000573	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—lung cancer	5.99e-05	0.000566	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	5.93e-05	0.000559	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOA1—lung cancer	5.92e-05	0.000559	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—MAPK3—lung cancer	5.9e-05	0.000557	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—lung cancer	5.87e-05	0.000554	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KDR—lung cancer	5.87e-05	0.000554	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BRAF—lung cancer	5.79e-05	0.000547	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6R—lung cancer	5.72e-05	0.00054	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CREBBP—lung cancer	5.72e-05	0.000539	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—lung cancer	5.69e-05	0.000537	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ERBB3—lung cancer	5.66e-05	0.000534	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—EGFR—lung cancer	5.62e-05	0.00053	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAP2K1—lung cancer	5.45e-05	0.000515	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—lung cancer	5.44e-05	0.000514	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TERT—lung cancer	5.42e-05	0.000512	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CD—lung cancer	5.42e-05	0.000511	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CG—lung cancer	5.41e-05	0.00051	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APC—lung cancer	5.41e-05	0.00051	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KIT—lung cancer	5.41e-05	0.00051	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—NRAS—lung cancer	5.4e-05	0.00051	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	5.37e-05	0.000507	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGF—lung cancer	5.34e-05	0.000504	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—KRAS—lung cancer	5.31e-05	0.000501	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGFR1—lung cancer	5.26e-05	0.000497	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HIF1A—lung cancer	5.19e-05	0.000489	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—MAPK3—lung cancer	5.18e-05	0.000489	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—lung cancer	5.14e-05	0.000486	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BRAF—lung cancer	5.08e-05	0.00048	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6R—lung cancer	5.02e-05	0.000474	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CREBBP—lung cancer	5.01e-05	0.000473	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOA1—lung cancer	5e-05	0.000472	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KDR—lung cancer	4.96e-05	0.000468	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EGFR—lung cancer	4.92e-05	0.000465	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	4.87e-05	0.00046	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MDM2—lung cancer	4.85e-05	0.000458	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RAF1—lung cancer	4.84e-05	0.000457	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ERBB2—lung cancer	4.79e-05	0.000452	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAP2K1—lung cancer	4.78e-05	0.000451	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CD—lung cancer	4.75e-05	0.000448	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MTOR—lung cancer	4.72e-05	0.000446	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CB—lung cancer	4.72e-05	0.000446	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	4.71e-05	0.000444	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—KRAS—lung cancer	4.65e-05	0.000439	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CG—lung cancer	4.57e-05	0.000431	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APC—lung cancer	4.57e-05	0.000431	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KIT—lung cancer	4.57e-05	0.000431	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—NRAS—lung cancer	4.57e-05	0.000431	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—lung cancer	4.54e-05	0.000428	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGF—lung cancer	4.52e-05	0.000426	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—HRAS—lung cancer	4.51e-05	0.000426	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—lung cancer	4.38e-05	0.000414	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—MAPK3—lung cancer	4.37e-05	0.000413	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—lung cancer	4.35e-05	0.00041	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CASP3—lung cancer	4.34e-05	0.00041	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—lung cancer	4.34e-05	0.000409	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—lung cancer	4.32e-05	0.000407	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BRAF—lung cancer	4.29e-05	0.000405	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	4.27e-05	0.000403	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MDM2—lung cancer	4.26e-05	0.000402	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RAF1—lung cancer	4.24e-05	0.0004	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6R—lung cancer	4.24e-05	0.0004	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CREBBP—lung cancer	4.24e-05	0.0004	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCND1—lung cancer	4.23e-05	0.000399	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JUN—lung cancer	4.22e-05	0.000398	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ERBB2—lung cancer	4.2e-05	0.000396	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EGFR—lung cancer	4.16e-05	0.000393	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MTOR—lung cancer	4.14e-05	0.000391	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CB—lung cancer	4.14e-05	0.000391	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—lung cancer	4.11e-05	0.000387	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CDKN1A—lung cancer	4.09e-05	0.000386	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTEN—lung cancer	4.08e-05	0.000385	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAP2K1—lung cancer	4.04e-05	0.000382	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CD—lung cancer	4.02e-05	0.000379	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—lung cancer	3.98e-05	0.000376	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—lung cancer	3.98e-05	0.000376	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	3.98e-05	0.000375	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—HRAS—lung cancer	3.95e-05	0.000373	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—KRAS—lung cancer	3.93e-05	0.000371	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EP300—lung cancer	3.89e-05	0.000367	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—lung cancer	3.84e-05	0.000363	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CASP3—lung cancer	3.81e-05	0.00036	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—lung cancer	3.8e-05	0.000359	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SRC—lung cancer	3.78e-05	0.000357	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—lung cancer	3.78e-05	0.000357	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCND1—lung cancer	3.71e-05	0.00035	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUN—lung cancer	3.7e-05	0.000349	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—lung cancer	3.69e-05	0.000348	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—lung cancer	3.65e-05	0.000345	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NRAS—lung cancer	3.64e-05	0.000344	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	3.61e-05	0.000341	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—lung cancer	3.6e-05	0.00034	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MDM2—lung cancer	3.6e-05	0.00034	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDKN1A—lung cancer	3.59e-05	0.000339	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RAF1—lung cancer	3.59e-05	0.000338	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTEN—lung cancer	3.58e-05	0.000338	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ERBB2—lung cancer	3.55e-05	0.000335	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MTOR—lung cancer	3.5e-05	0.00033	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CB—lung cancer	3.5e-05	0.00033	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—lung cancer	3.49e-05	0.00033	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK3—lung cancer	3.49e-05	0.000329	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EP300—lung cancer	3.41e-05	0.000322	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MYC—lung cancer	3.39e-05	0.00032	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—lung cancer	3.36e-05	0.000317	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HRAS—lung cancer	3.34e-05	0.000315	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SRC—lung cancer	3.32e-05	0.000313	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGFR—lung cancer	3.32e-05	0.000313	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—lung cancer	3.25e-05	0.000307	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—lung cancer	3.23e-05	0.000305	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP3—lung cancer	3.22e-05	0.000304	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—lung cancer	3.21e-05	0.000303	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—lung cancer	3.2e-05	0.000302	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—lung cancer	3.2e-05	0.000302	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NRAS—lung cancer	3.19e-05	0.000301	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KRAS—lung cancer	3.13e-05	0.000296	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCND1—lung cancer	3.13e-05	0.000296	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUN—lung cancer	3.13e-05	0.000295	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK3—lung cancer	3.06e-05	0.000289	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—lung cancer	3.04e-05	0.000287	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDKN1A—lung cancer	3.03e-05	0.000286	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTEN—lung cancer	3.02e-05	0.000285	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MYC—lung cancer	2.97e-05	0.000281	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—lung cancer	2.95e-05	0.000279	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGFR—lung cancer	2.91e-05	0.000275	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EP300—lung cancer	2.88e-05	0.000272	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CA—lung cancer	2.88e-05	0.000272	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SRC—lung cancer	2.8e-05	0.000265	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TP53—lung cancer	2.79e-05	0.000263	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KRAS—lung cancer	2.75e-05	0.000259	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—lung cancer	2.73e-05	0.000258	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—lung cancer	2.71e-05	0.000255	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NRAS—lung cancer	2.7e-05	0.000255	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HRAS—lung cancer	2.66e-05	0.000251	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK3—lung cancer	2.58e-05	0.000244	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—lung cancer	2.55e-05	0.000241	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CA—lung cancer	2.52e-05	0.000238	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MYC—lung cancer	2.51e-05	0.000237	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGFR—lung cancer	2.46e-05	0.000232	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TP53—lung cancer	2.44e-05	0.000231	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—lung cancer	2.35e-05	0.000222	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HRAS—lung cancer	2.34e-05	0.00022	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KRAS—lung cancer	2.32e-05	0.000219	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—lung cancer	2.24e-05	0.000211	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CA—lung cancer	2.13e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TP53—lung cancer	2.06e-05	0.000195	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—lung cancer	2.06e-05	0.000195	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HRAS—lung cancer	1.97e-05	0.000186	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—lung cancer	1.89e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—lung cancer	1.74e-05	0.000165	CbGpPWpGaD
